In addition, RNA interference technology was used to explore the possible mechanism through which TBL1XR1 regulates triglyceride (TG) metabolism through the PPAR pathway, thereby promoting the occurrence and development of CAD. This evidence concerns the gene TBL1XR1 and coronary artery disorder.